首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Personalized medicine

缩写:PERS MED

ISSN:1741-0541

e-ISSN:1744-828X

IF/分区:1.2/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引1302条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kosar Shirvani Baghbabouie,Danial Jahantigh,Forough Forghani et al. Kosar Shirvani Baghbabouie et al.
Aims: This study investigated the association between BAFF gene polymorphisms (rs1041569 and rs9514828) and preeclampsia (PE) susceptibility in an Iranian population, with a focus on disease severity and onset timing. ...
Rümeysa Karaismailoğlu,Nilgün Bozbuğa Rümeysa Karaismailoğlu
Introduction: The paradigm of personalized medicine is rapidly shifting from traditional, evidence-based genomics to advanced, data-driven ecosystems. Understanding this transition, supported by the computational tools of...
Nidhi Mahajan,Vishal Chopra,Kranti Garg et al. Nidhi Mahajan et al.
Background: Chronic obstructive pulmonary disease (COPD) ranks among the leading causes of morbidity and mortality globally. Genomic susceptibility factors are acknowledged as critical modulators of disease variability an...
Susanne B Haga,Meghan MacNeal Susanne B Haga
Aims: The rapid integration of genetics into clinical care and research has outpaced the supply of genetic professionals, creating persistent challenges in patient education, communication, and clinical follow-up. Chatbot...
Shrivats Manikandan,Steiv Shore,Daniel Waszczuk et al. Shrivats Manikandan et al.
Introduction: Chronic diseases remain leading contributors to global mortality, yet digital biomarkers offer transformative potential for personalized management. This systematic review evaluates the clinical performance ...
Vanessa Obourn,Shalaka Patel,Gonzalo Lopez et al. Vanessa Obourn et al.
Background: Measurable residual disease (MRD) is a key prognostic factor in acute myeloid leukemia (AML). The Measurable residual disease Partnership and Alliance in Acute Myeloid Leukemia Clinical Treatment (MPAACT) Cons...
Haifa Guo,Jiawei Li,Tao Li et al. Haifa Guo et al.
Objective: This study aimed to investigate the expression levels of microRNA-550a-5p (miR-550a-5p) in patients with spinal metastases from non-small cell lung cancer (NSCLC) and to explore its clinical significance. ...
Aliakbar Mariki,Seyed Mohammad Mousavi,Kristi Anne Kohlmeier et al. Aliakbar Mariki et al.
Multiple sclerosis (MS) is a complex neurological disorder with inflammation, demyelination, and neurodegeneration in the CNS. Disease-modifying therapies (DMTs) exist, but their efficacy is limited by MS's varied nature, highlighting the n...
Vishal S Patil,Chandragouda R Patil,Rohit Paul et al. Vishal S Patil et al.
Background: Fibrosis is a systemic disorder driven by inflammation, immune imbalance, and extracellular matrix remodeling. Pirfenidone (PFD) and nintedanib (NTB), approved for idiopathic pulmonary fibrosis, may exert broa...
Siwei Luo,Jinrong Li,Yu Zhang et al. Siwei Luo et al.
Introduction: The functional single nucleotide polymorphism (SNP) rs767649 in the miR-155 gene has been linked to other neurological disorders, but its association with sporadic Parkinson's disease (PD) remains unclear. ...